Last $89.81 USD
Change Today -0.26 / -0.29%
Volume 833.7K
NVS On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Frankfurt
SIX Swiss Ex
As of 4:15 PM 07/10/14 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for novartis ag-adr (NVS)

Currency in
Millions of US Dollars
As of:Dec 31
2010
Dec 31
2011
Dec 31
2012
Restated
Dec 31
2013
4 Year
Trend
NET INCOME9,794.09,113.09,270.09,175.0
Depreciation & Amortization1,363.01,728.01,704.01,755.0
Amortization of Goodwill and Intangible Assets1,135.03,028.02,894.02,976.0
DEPRECIATION & AMORTIZATION, TOTAL2,498.04,756.04,598.04,731.0
(Gain) Loss from Sale of Asset-429.0-518.0-294.0-395.0
(Gain) Loss on Sale of Investment158.0192.034.065.0
Asset Writedown & Restructuring Costs921.01,032.0322.0194.0
Other Operating Activities793.01,056.01,383.01,028.0
(Income) Loss on Equity Investments-804.0-528.0-552.0-600.0
Change in Accounts Receivable26.0-732.0369.0-411.0
Change in Inventories965.045.0-701.0-653.0
Change in Accounts Payable490.0195.0515.0502.0
Change in Other Working Capital-1,000.0-1,092.0-1,496.0-1,192.0
CASH FROM OPERATIONS14,067.014,309.014,194.013,174.0
Capital Expenditure-1,678.0-2,167.0-2,698.0-3,064.0
Sale of Property, Plant, and Equipment36.061.092.060.0
Cash Acquisitions-26,666.0-591.0-1,741.0-42.0
Divestitures--22.0----
Sale (Purchase) of Intangible Assets-9.0423.0-207.0-353.0
Investments in Marketable & Equity Securities12,573.01,503.0-1,082.069.0
CASH FROM INVESTING-15,756.0-792.0-5,675.0-3,352.0
Short-Term Debt Issued2,610.0----596.0
Long-Term Debt Issued5,674.0281.01,979.093.0
TOTAL DEBT ISSUED8,284.0281.01,979.0689.0
Short Term Debt Repaid---3,054.0-1,737.0--
Long Term Debt Repaid-5.0-28.0-704.0-2,022.0
TOTAL DEBT REPAID-5.0-3,082.0-2,441.0-2,022.0
Issuance of Common Stock711.0159.0414.01,693.0
Repurchase of Common Stock-311.0-3,628.0-505.0-2,930.0
Common Dividends Paid-4,486.0-5,368.0-6,030.0-6,100.0
TOTAL DIVIDEND PAID-4,486.0-5,368.0-6,030.0-6,100.0
Other Financing Activities-77.0-3,386.0-92.0-99.0
CASH FROM FINANCING4,116.0-15,024.0-6,675.0-8,769.0
Foreign Exchange Rate Adjustments-2.0-103.0-1.082.0
NET CHANGE IN CASH2,425.0-1,610.01,843.01,135.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVS:US $89.81 USD -0.26

NVS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Merck & Co Inc $58.58 USD +0.03
Nestle SA SFr.68.45 CHF -0.35
Pfizer Inc $30.00 USD -0.05
Roche Holding AG SFr.262.20 CHF -3.30
Procter & Gamble Co/The $81.61 USD -0.06
View Industry Companies
 

Industry Analysis

NVS

Industry Average

Valuation NVS Industry Range
Price/Earnings 22.9x
Price/Sales 3.7x
Price/Book 3.1x
Price/Cash Flow 25.0x
TEV/Sales 3.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.